Liver health and drug safety: new study tests golcadomide
NCT ID NCT06535399
First seen Nov 12, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study looked at how the drug golcadomide is handled by the body in people with moderate or severe liver damage compared to healthy volunteers. 29 adults received a single dose to measure drug levels and check for side effects. The goal was to understand dosing needs for patients with liver problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Chandler, Arizona, 85225, United States
-
Local Institution - 0002
Orlando, Florida, 32809, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.